The rise of theranostics: Part 2 -- Moving into communities
A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. That has changed and the field of theranostics is expanding rapidly in various ways, as described in part 1 of AuntMinnie.com's series on the rise of theranostics.
However, few freestanding theranostics centers exist today. Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. They're also mindful of the multiple dedicated teams required to build a thera...
Source: AuntMinnie.com Headlines - April 4, 2024 Category: Radiology Authors: Liz Carey Tags: Practice Management Radiation Oncology/Therapy Nuclear Medicine Medicolegal Genitourinary Radiology Source Type: news
The truth about thyroids: How women are told they're depressed or menopausal when it's actually an underactive thyroid. And others are prescribed drugs they don't even need
Experts say, it can take years for the condition to be diagnosed - with patients, who are usually women, still not being listened to when they go to the doctor, (Source: the Mail online | Health)
Source: the Mail online | Health - April 3, 2024 Category: Consumer Health News Source Type: news
Microwave Treatment Could Be an Advance Against Thyroid Tumors
WEDNESDAY, April 3, 2024 -- Microwaves could offer an alternative to surgery for some people with thyroid cancer, a new study suggests.Microwave ablation, which uses heat to destroy tumors, more effectively targeted thyroid cancers on multiple... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 3, 2024 Category: General Medicine Source Type: news
Microwave Ablation a Safer Option for Multifocal Papillary Thyroid Carcinoma?
(MedPage Today) -- The use of microwave ablation to treat ultrasound-detected, multifocal papillary thyroid carcinoma (PTC) was associated with the same outcomes but fewer complications compared with surgical resection, according to results from... (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - April 2, 2024 Category: Radiology Source Type: news
John Midgley obituary
My colleague and friend John Midgley, who has died aged 88, was a scientist, biochemist and researcher best known for the invention and development of thyroid hormone blood tests in the 1980s.A pioneer in medical biochemistry, his work in the field of thyroid hormone detection hugely improved patient care. John was also a passionate advocate for patients – as a medical adviser to the charity Thyroid UK, commentator and writer.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 2, 2024 Category: Science Authors: Rudolf Hoermann Tags: Thyroid disorders Science Medical research Biochemistry and molecular biology Yorkshire Healthcare industry University of Leeds University of Oxford Newcastle University Source Type: news
Microwave ablation on par with surgery for thyroid cancer survival
Microwave ablation may be a suitable alternative to surgical resection when it comes to ultrasound-detected thyroid cancer, a study published April 2 in Radiology found.
Researchers led by Zhen-Long Zhao, MD, from China-Japan Friendship Hospital in Beijing found no significant difference in progression-free survival rates between patients receiving ablation or surgery. Additionally, microwave ablation led to less blood loss, shorter incision length, and shorter procedure and hospitalization durations.
“Microwave ablation is a feasible option for selected patients with multifocal T1N0M0 papillary thyroid carcinoma,” Z...
Source: AuntMinnie.com Headlines - April 2, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Source Type: news
Blood tests say my hypothyroidism is under control. So why do I feel so exhausted? Ask the GP DR MARTIN SCURR
Your experience - when blood tests show levels of thyroid hormones have been corrected, yet you continue to feel tired - is not uncommon, says DR MARTIN SCURR. (Source: the Mail online | Health)
Source: the Mail online | Health - April 1, 2024 Category: Consumer Health News Source Type: news
What Do the Data Say About Desiccated Thyroid Extract? What Do the Data Say About Desiccated Thyroid Extract?
Non-randomised studies showed benefit in treating hypothyroidism, whereas randomised controlled trials did not.Medscape UK (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 27, 2024 Category: Internal Medicine Tags: Diabetes & Endocrinology Source Type: news
The rise of theranostics: Part 1 -- Gaining momentum
Since the U.S. Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research.Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After the therapeutic agent binds to the cancer cells, the tumors are treated in such a way that aims to prevent collateral damage to healthy cells and improve overall outcomes.Theranostics isn’t new; nuclear medicine d...
Source: AuntMinnie.com Headlines - March 26, 2024 Category: Radiology Authors: Liz Carey Tags: Practice Management Molecular Imaging Radiation Oncology/Therapy Nuclear Medicine Source Type: news
How to survive cancer, from the man who has beaten the disease five times
Bill Potts from Florida has survived cancer five times: thyroid cancer once and non-Hodgkin lymphoma four times. 'It sounds odd to even say those words. It's such a big number,' he said. (Source: the Mail online | Health)
Source: the Mail online | Health - March 24, 2024 Category: Consumer Health News Source Type: news
Can ChatGPT-4 accurately interpret thyroid, renal ultrasound images?
ChatGPT-4 demonstrated high accuracy in analyzing and interpreting thyroid and renal ultrasound images in a small study published March 19 in Radiology Advances.
Researchers led by Laith Sultan, MD, from Children’s Hospital of Philadelphia reported that the large language model could accurately perform image segmentation and classify lesions on ultrasound as normal or abnormal.
“These functionalities indicate the tool's potential to improve radiological workflows by pre-screening and categorizing ultrasound images,” Sultan told AuntMinnie.com. “This technology, if implemented in clinical practice, will have great...
Source: AuntMinnie.com Headlines - March 22, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Ultrasound Advanced Visualization Genitourinary Radiology Head and Neck Radiology Source Type: news
ChatGPT-4 accurately interprets thyroid, renal ultrasound images
ChatGPT-4 demonstrated high accuracy in analyzing and interpreting thyroid and renal ultrasound images in a study published March 19 in Radiology Advances.
Researchers led by Laith Sultan, MD, from Children’s Hospital of Philadelphia reported that the large language model could accurately perform image segmentation and classify lesions on ultrasound as normal or abnormal.
“These functionalities indicate the tool's potential to improve radiological workflows by pre-screening and categorizing ultrasound images,” Sultan told AuntMinnie.com. “This technology, if implemented in clinical practice, will have great poten...
Source: AuntMinnie.com Headlines - March 22, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Ultrasound Advanced Visualization Genitourinary Radiology Head and Neck Radiology Source Type: news
Dietitian warning as trendy sea moss gel linked to debilitating thyroid disease - as Bella Hadid promotes it in her 'nonsense' morning routine video
Doctors in Conneticut have warned of the risks of ingesting too much of the supplement sea moss gel, popular with celebrities such as Bella Hadid, after a patient developed thyroid disease. (Source: the Mail online | Health)
Source: the Mail online | Health - March 21, 2024 Category: Consumer Health News Source Type: news
ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneous Anti-IGF-1R to Demonstrate Clinical Responses in Thyroid …
Rapid improvements demonstrated for proptosis, clinical activity scores, and diplopia versus placebo with a favorable safety profile Phase 2b/3 trial to be initiated in the second half of 2024 Conference call to review these data to be held at 8:30 a.m. ET today LOS ANGELES, March 20, 2024 (GLOBE…#phase2b3 #phase12 #cas #iv #shaoleelin #phd #acelyrin #cohort1 #cohort2 #teprotumumabsmith (Source: Reuters: Health)
Source: Reuters: Health - March 20, 2024 Category: Consumer Health News Source Type: news
Ozempic Gets the Oprah Treatment in a New TV Special
Weight-loss drugs like Ozempic, Wegovy, and Zepbound are already extremely popular: by 2030, about 10% of the U.S. population will be on one of these drugs and the category’s sales will surpass $100 billion, according to some projections. On March 18, they got another major cultural boost from Oprah Winfrey, who shared her own experience with—and support for—these medications in an ABC special called “Shame, Blame and the Weight Loss Revolution.”
[time-brightcove not-tgx=”true”]
During the special, Winfrey talked about how using one of these weight-loss drugs (she did not say w...
Source: TIME: Health - March 19, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news
